Mike Gitlin, President, and CEO of Capital Group welcomes delegates and speakers to our inaugural Framing the Future summit.

Mike Gitlin

President, and CEO of Capital Group

Brooke Masters who is US financial editor, Financial Times summarises the day's agenda and the engaging and entertaining sessions planned for the summit over both morning and afternoon.

Brooke Masters

US Financial Editor and an Associate Editor at the Financial Times

Martin Wolf provides a unique perspective on the global economy following an unprecedented year of elections and democratic change, highlighting the lasting impact of these political shifts on global markets and international relations.

Martin Wolf

Bestselling author, Associate Editor and Chief Economics Commentator, Financial Times

How will Artificial Intelligence change the future of health, work and family … and will it be for the better or worse?

Nobel laureate, leading biochemist and author, Dr. Jennifer Doudna describes her joint discovery of CRISPR-Cas9 as a revolutionary tool for making targeted changes to an organism's genome. Armed with the CRISPR toolkit, scientists can exert nearly complete control over the composition of the genome and its output. Offering opportunities for new and exciting healthcare therapies, this powerful technology extends into areas such agricultural genetics, raising strong ethical considerations on its responsible use.

Dr. Jennifer Doudna

Nobel Prize Winner, founder of the Innovative Genomics Institute, and Professor of Molecular and Cell Biology and Professor of Chemistry at UC Berkeley

Technological change and advancements in scientific research offer significant opportunities in healthcare including enhanced diagnostics, genomic editing and precision neuroscience. All are likely to be greatly amplified by the potential benefits of AI. What is the likely impact of these developments, and will healthcare shift from treatment to more cost-effective disease prevention?

Panel discussion with Dr. Jennifer Doudna and Capital Group investment professionals.

Who are the likely winners of the energy transition race? As the world's search to secure a greener future accelerates, where are the opportunities and challenges?

Emerging markets represent most of the world's population and a high proportion of GDP growth. The rise of the middle class, digitization and geopolitical shifts will drive enormous changes over the next decade. Will the emerging markets we know today be considered 'emerging' in 10 years' time?

Framed on one side by environmental and social challenges and on the other by changing demographics and consumer preferences, we can expect global food demand and supply patterns to change significantly over the next decade. Accelerated in part by the emergence of GLP-1 therapies, we explore the future state of the global food sector.

Panel discussion with Giles Yeo and Capital Group investment professionals.

Giles Yeo

Professor of Molecular Neuroendocrinology and programme leader at the MRC Metabolic Diseases Unit, University of Cambridge

Join us for dinner and the opportunity to network with your peers, the day's presenters and senior representatives of Capital Group.